Hyoscini butylbromidum
This medicine should always be used exactly as described in the patient leaflet or as directed by your doctor or pharmacist.
Scopolan is a medicine containing butylbromide of hyoscine, which relieves smooth muscle spasms in the abdominal cavity. The antispasmodic effect helps to alleviate painful spasms of the digestive tract, bile ducts, and the urinary and genital systems.
Scopolan is used for painful conditions associated with spasms:
You should not use Scopolan if you are allergic to the active substance - butylbromide of hyoscine or any of the other ingredients of this medicine (listed in section 6). You should not use Scopolan if you have:
This medicine should only be taken as needed (when symptoms occur) and in the recommended indications. If you experience sudden abdominal pain of unknown cause, accompanied by fever, nausea, vomiting, changes in bowel movements (e.g., diarrhea), abdominal tenderness, decreased blood pressure, fainting, or blood in the stool, you should not take the medicine without consulting a doctor. To investigate the cause of the symptoms, the doctor will recommend diagnostic tests.
Do not use in children under 6 years of age. Use in older children - see section 3.
You should tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take. Before starting Scopolan, consult your doctor if you are taking:
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before using this medicine. Pregnancy There are no clinical studies confirming the safety of using butylbromide of hyoscine during pregnancy. The medicine should not be used during pregnancy unless the doctor considers it absolutely necessary. Breastfeeding There are no data on the passage of butylbromide of hyoscine into breast milk. Medicines from this group may inhibit milk production, so it is not recommended to use Scopolan during breastfeeding. The effect on fertility is unknown.
During treatment, you should not drive vehicles or operate machines, as the medicine may cause impaired physical and mental performance and vision disturbances.
If you have previously been diagnosed with intolerance to some sugars, you should consult your doctor before taking the medicine.
This medicine should always be used exactly as described in the patient leaflet or as directed by your doctor or pharmacist. If you have any doubts, you should consult your doctor or pharmacist. The medicine should only be used as needed (when symptoms occur). The recommended dose is: Adults:
Adolescents over 12 years of age:
Children between 6 and 12 years of age:
You should always use the smallest effective dose. If symptoms persist for more than 3 days after starting treatment or worsen despite using the medicine, you should stop using the medicine and consult a doctor.
If you have taken a higher dose of Scopolan than recommended, you should immediately consult a doctor. In humans, no severe poisoning symptoms have been observed after a single acute overdose. Symptoms such as urinary retention, dry mouth, tachycardia (accelerated heart rate), dizziness, and transient vision disturbances may occur.
You should not take a double dose to make up for a missed dose.
Scopolan should only be used as needed and its use should be stopped after symptoms have resolved. If you have any further doubts about using this medicine, you should consult your doctor or pharmacist.
Like all medicines, Scopolan can cause side effects, although not everybody gets them. The medicinal product used in recommended therapeutic doses is well-tolerated, and any side effects that may occur are of moderate severity. Side effects of the medicine are presented according to the classification of organs and systems and frequency of occurrence: uncommon (occurring less frequently than in 1 in 100 patients, but more frequently than in 1 in 1000 patients); rare (occurring less frequently than in 1 in 1000 patients, but more frequently than in 1 in 10,000 patients); unknown (cannot be determined based on available data). When using Scopolan, the following side effects may occur: skin and subcutaneous tissue disorders: flushing, skin burning, itching, rash, urticaria, edema - uncommon; gastrointestinal disorders: dry mouth, constipation - uncommon; cardiac disorders: tachycardia (accelerated heart rate) - uncommon; vascular disorders: hypotension (low blood pressure) - uncommon; renal and urinary disorders: anuria (urinary retention) - rare; eye disorders: vision disturbances - rare; immune system disorders: anaphylactic reactions (allergic reactions), anaphylactic shock (a sudden and severe allergic reaction characterized by difficulty breathing, significant drop in blood pressure, swelling, rash) - frequency unknown. If you experience any of the above symptoms, you should immediately stop using the medicine and consult a doctor.
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help gather more information on the safety of the medicine.
Store at a temperature below 25°C. The medicine should be stored out of sight and reach of children. Do not use this medicine after the expiration date stated on the packaging. The expiration date refers to the last day of the specified month. Medicines should not be disposed of via wastewater or household waste containers. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Scopolan is a white, chewable tablet. Packaging: aluminum/PVC blister pack in a cardboard box. Pack size: 10 or 30 chewable tablets.
Wrocławskie Zakłady Zielarskie "Herbapol" SA, 50-951 Wrocław, ul. św. Mikołaja 65/68, Tel.: +48 71 33 57 225, Fax: +48 71 372 47 40, e-mail: herbapol@herbapol.pl. For more detailed information about this medicine, you should contact the marketing authorization holder - tel. 71 321 86 04 ext. 123
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.